The other fungi: It's not just Candida albicans anymore

Surgical Infections

Volumn 7, Issue 2, 2006, Pages 143-150

  Saalwachter, Alison R ^a   Hedrick, Traci ^a   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; VORICONAZOLE;

ASPERGILLOSIS; ASPERGILLUS; BLASTOMYCES; CANDIDA; CANDIDA ALBICANS; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; CONSULTATION; CRITICALLY ILL PATIENT; CRYPTOCOCCUS NEOFORMANS; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGAL VIRULENCE; FUNGUS CULTURE; GENUS; HISTOPLASMA; HISTOPLASMOSIS; HUMAN; IMMUNE DEFICIENCY; KIDNEY DISEASE; MYCOSIS; PATHOGENESIS; PATIENT CARE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; SURGEON; SURGICAL PATIENT; TREATMENT OUTCOME; ZYGOMYCETES;

CROSS INFECTION; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOSES; SURGICAL PROCEDURES, OPERATIVE;

EID: 33646704198     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.143     Document Type: Review

References (36)

1. Glick M, Siegel MA. Viral and fungal infecions of the oral cavity in immunocompetent patients. Infect Dis Clin North Am 1999;13:817-831.
2. Safdar A, Bannister TW, Safdar Z. The predictors of outcome in immunocompetent patients with hematogenous candidasis. Int J Infect Dis 2004;8:180-186.
3. Hughes MG, Chong TW, Smith RL, et al. Comparison of fungal and nonfungal infections in a broad-based surgical patient population. Surg Infect (in press).
4. Hartsel S, Bolard J. Amphotericin B: A new life for an old drug. TiPS 1996;17:445-449.
5. Centers for Disease Control and Prevention. Monitoring hospital-acquired infections to promote patient safety - United States, 1990-1999. MMWR 2000;49: 149-153.
6. Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 1999;29: 239-244.
7. Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004;23:317-322.
8. Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis 2004;38:311-320.
9. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-140.
10. Hajjeh RA, Sofair AN, Harrison LH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004;42:1519-1527.
11. Klingspor L, Tornqvist E, Johansson A, et al. A prospective epidemiological survey of candidaemia in Sweden. Scand J Infect Dis 2004;36:52-55.
12. Gleason TG, May AK, Caparelli D, et al. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg 1997;132: 1197-1201.
13. Dean DA, Burchard KW. Surgical perspectives on invasive Candida infections. World J Surg 1998;22: 127-134.
14. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000;30:662-678.
15. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38: 161-189.
16. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-1330.
17. El-Ebiary M, Torres A, Fabrega N, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. Am J Respir Crit Care Med 1997;156:583-590.
18. Levy I, Rubin LG, Vasishtha S, et al. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998; 26:1086-1088.
19. Kossoff EH, Buescher SE, Karlowicz GM. Candidemia in a neonatal intensive care unit: Trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998;17:504-508.
20. Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003;37:634-643.
21. Diamond RD. Cryptococcus neoformans. In Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone, 2000:2707-2716.
22. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-1751.
23. Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis: Clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981;94: 611-616.
24. Warris A. Contamination of hospital water with Aspergillus fumigatus and other molds. Clin Infect Dis 2002;34:1159-1160.
25. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000;30:696-709.
26. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: A review of 2121 published cases. Rev Infect Dis 1990;12:1147-1201.
27. Hay RJ. Antifungal drugs used for systemic mycoses. Dermatol Clin 2003;21:577-587.
28. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am 2002;16:895-914.
29. Rangel-Guerra RA, Martinez HR, Saenz C, et al. Rhinocerebral and systemic mucormycosis: Clinical experience with 36 cases. J Neurol Sci 1996;143:19-30.
30. Gaviria JM, Grohskopf LA, Barnes R, Root RK. Successful treatment of rhinocerebral zygomycosis: A combined-strategy approach. Clin Infect Dis 1999; 28:160-161.
31. Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:688-695.
32. Leef JL III, Klein JS. The solitary pulmonary nodule. Radiol Clin North Am 2002;40:123-143.
33. Dickson E. "Valley fever" of the San Joaquin Valley and fungus Coccidioides. Calif West Med 1937; 47:151-155.
34. Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis. Infect Dis Clin North Am 2003;17: 41-57.
35. Galgiani JN, Ampel NM, Catanzaro A, et al. Practice guidelines for the treatment of fungal coccidioidomycosis. Clin Infect Dis 2000;30:658-661.
36. Ayi BS, Rupp ME. Blastomyosis. In Rakel RE and Bope ET, eds. Conn's Current Therapy 2005, 57th ed. St. Louis: Elsevier. 2005:278-280.